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Abstract Mendelian randomization-Egger (MR-Egger) is
an analysis method for Mendelian randomization using
summarized genetic data. MR-Egger consists of three
parts: (1) a test for directional pleiotropy, (2) a test for a
causal effect, and (3) an estimate of the causal effect.
While conventional analysis methods for Mendelian ran-
domization assume that all genetic variants satisfy the
instrumental variable assumptions, the MR-Egger method
is able to assess whether genetic variants have pleiotropic
effects on the outcome that differ on average from zero
(directional pleiotropy), as well as to provide a consistent
estimate of the causal effect, under a weaker assumption—
the InSIDE (INstrument Strength Independent of Direct
Effect) assumption. In this paper, we provide a critical
assessment of the MR-Egger method with regard to its
implementation and interpretation. While the MR-Egger
method is a worthwhile sensitivity analysis for detecting
violations of the instrumental variable assumptions, there
are several reasons why causal estimates from the MR-
Egger method may be biased and have inflated Type 1 error
rates in practice, including violations of the InSIDE
assumption and the influence of outlying variants. The
issues raised in this paper have potentially serious
consequences for causal inferences from the MR-Egger
approach. We give examples of scenarios in which the
estimates from conventional Mendelian randomization
methods and MR-Egger differ, and discuss how to interpret
findings in such cases.
Keywords Mendelian randomization  Instrumental
variable  Robust methods  MR-Egger  Summarized data
Introduction
The technique of Mendelian randomization has become a
widely-used part of the epidemiologist’s toolkit for inves-
tigating causal relationships between risk factors and out-
comes using observational data [1, 2]. Although in some
cases, the necessary assumption that genetic variants are
valid instrumental variables is credible, in other cases the
instrumental variable assumptions are not plausible [3].
The instrumental variable assumptions state that a genetic
variant used in a Mendelian randomization investigated
must be:
1. associated with the risk factor;
2. not associated with any confounder of the risk factor–
outcome association;
3. not associated with the outcome conditional on the risk
factor and confounders [4, 5].
This implies that there is no alternative causal pathway
from the genetic variant to the outcome except for that via
the risk factor [6]. These assumptions may be reasonable
when the risk factor is a protein biomarker and the genetic
variants are located in or around the coding region for that
protein. In such a case, causal inferences from a straight-
forward application of instrumental variable methods have
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some credibility. However, they are more questionable for
polygenic risk factors, such as body mass index or blood
pressure, as the influence of genetic variants on such a risk
factor is unlikely to be specific [7, 8].
Mendelian randomization-Egger (MR-Egger) is a sta-
tistical method that can be employed when the instrumental
variable assumptions do not hold, but a weaker assumption
is satisfied [9]. The method is being increasingly used in
practice, with applications including analyses of the causal
effects of plasma urate on coronary heart disease risk [10],
of height on income [11], of sleep patterns on type 2 dia-
betes [12], and of pubertal development on prostate cancer
risk [13]. However, critical assessment of the method is
lacking. In this paper, we first discuss implementation of
the MR-Egger method. We then provide guidance to the
applied practitioner in what circumstances the method will
give reasonable estimates, and how to interpret these esti-
mates, particularly for cases where the MR-Egger and
conventional methods for Mendelian randomization give
different results.
Implementation of the MR-Egger method
MR-Egger consists of three parts: (1) a test that indicates
both violations of the instrumental variable assumptions
and bias in conventional instrumental variable analysis
methods; (2) a test for a causal effect; and (3) an estimate
of the causal effect. Software code in R for implementing
all of the analyses in this paper is provided in ‘‘Appendix
A.1’’ in supplementary material.
Assumed framework of data and genetic
associations
We assume that all relationships between variables (in
particular, the genetic associations with the risk factor and
with the outcome, and the causal effect of the risk factor on
the outcome) are linear with no effect modification. We
also assume that all genetic variants are uncorrelated (that
is, not in linkage disequilibrium), although conventional
instrumental variable methods for analysing summarized
data from correlated variants have been developed [14],
and similar extensions to the MR-Egger method are dis-
cussed later in this paper. The association between genetic
variant Gj (j ¼ 1; 2; . . .; J) and the outcome is denoted bYj,
and the association between genetic variant Gj and the risk
factor is denoted bXj.
The genetic association with the outcome can be
decomposed into the sum of a direct (pleiotropic) effect
and an indirect (causal) effect:
bYj ¼ aj þ hbXj ð1Þ
where aj is the effect of the genetic variant on the outcome
that is not mediated via the risk factor of interest, and h is
the causal effect of the risk factor on the outcome [15]; see
Fig. 1. A genetic variant is referred to as pleiotropic if it
has associations with more than one risk factor on different
causal pathways [16]. Any such effect is included in the
parameter aj; a genetic variant is pleiotropic if aj 6¼ 0. A
pleiotropic genetic variant is not a valid instrumental
variable.
Inverse-variance weighted method
With a single genetic variant Gj that satisfies the instru-
mental variable assumptions, the causal effect of the risk
factor on the outcome can be consistently estimated as a
simple ratio of association estimates: h^j ¼ b^Yjb^Xj [16], where
b^Yj is the estimated coefficient from univariable regression
of the outcome on the jth genetic variant, and likewise b^Xj
from univariable regression of the risk factor on the jth
genetic variant. With multiple genetic variants, the ratio
estimates from each genetic variant can be averaged using
an inverse-variance weighted formula taken from the meta-
analysis literature to provide an overall causal estimate
known as the inverse-variance weighted (IVW) estimate
[17]. This assumes that the ratio estimates all provide
independent evidence on the causal effect; this occurs
when the genetic variants are uncorrelated. If the variance
terms are taken as
seðb^YjÞ2
b^2Xj
(this is the first term from a delta
method expansion for the ratio estimate [18]), then the
pooled estimate (assuming a fixed-effect model) is [19]:
h^IVW ¼
P
j b^Yjb^Xjseðb^YjÞ2
P
j b^
2
Xjseðb^YjÞ2
: ð2Þ
This same estimate is obtained from the two-stage least
squares analysis method for individual-level data when the
genetic variants are uncorrelated [20]. The same estimate
can also be obtained from a weighted linear regression of
the genetic associations with the outcome (b^Yj) on the
Genetic
variant Gj
Risk
factor
X
Outcome
Y
causal effect of risk 
factor on outcome ( )
association of genetic
variant with risk factor ( Xj)
pleiotropic / direct effect of
genetic variant on outcome ( j)
Fig. 1 Decomposing association for genetic variant Gj with the
outcome into a indirect (causal) effect via the risk factor and an direct
(pleiotropic) effect (see Eq. 1)
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genetic associations with the risk factor (b^Xj) using inverse-
variance weights (seðb^YjÞ2) when there is no intercept
term in the regression model [14]:
b^Yj ¼ hIVW b^Xj þ Ij; IjNð0; r2seðb^YjÞ2Þ ð3Þ
where b^Yj and b^Xj are the data in the model, hIVW is the
parameter, and Ij is the residual term. To obtain the same
standard error for the causal estimate from the regression
analysis as from the fixed-effect meta-analysis, the residual
standard error in the regression (r) must be set to equal one
[21].
If the pleiotropic effects of the genetic variants are all
zero (aj ¼ 0 for all j; in other words, if all genetic variants
are valid instrumental variables), then each of the h^j will be
a consistent estimate of the causal effect, and the overall
estimate h^IVW (a weighted mean of the h^j) will be a con-
sistent estimate of the causal effect.
MR-Egger method
MR-Egger is performed by a simple modification to the
weighted linear regression described above. Rather than
setting the intercept term to be zero, the term is estimated
as part of the analysis [9]:
b^Yj ¼ h0E þ h1Eb^Xj þ Ej; EjNð0; r02seðb^YjÞ2Þ ð4Þ
where the parameter h0E is the intercept, h1E is the slope
(MR-Egger estimate), and Ej is the residual term. If the
intercept term is exactly equal to zero, then the MR-Egger
estimate will equal the IVW estimate. Alternatively, if the
pleiotropic effects aj are independently distributed from the
genetic associations with the risk factor bXj [22] – this is
referred to as the InSIDE assumption (INstrument Strength
Independent of Direct Effect) – then the MR-Egger esti-
mate will be a consistent estimate of the causal effect as the
sample size and number of genetic variants both increase
[9]. For a fixed number of genetic variants, the MR-Egger
estimate is a consistent estimate as the sample size
increases if the weighted covariance between the aj and the
bXj parameters using the inverse-variance weights
seðb^YjÞ2 is exactly zero (see ‘‘Appendix A.2’’ in supple-
mentary material). The test of whether the MR-Egger
estimate differs from zero is referred to as the MR-Egger
causal test.
Under the InSIDE assumption, the intercept from the
MR-Egger analysis can be interpreted as the average
pleiotropic effect of a genetic variant included in the
analysis (the weighted mean of the aj using the inverse-
variance weights seðb^YjÞ2). If the average pleiotropic
effect is zero (known as balanced pleiotropy), then the
IVW method gives a consistent estimate of the causal
effect (under the InSIDE assumption). Conversely, if the
intercept from the MR-Egger analysis is not equal to zero,
then either the average pleiotropic effect differs from zero
(known as directional pleiotropy) or the InSIDE assump-
tion is violated (or both). Hence, testing the intercept from
the MR-Egger analysis provides an assessment of the
validity of the instrumental variable assumptions, with a
non-zero intercept indicating that the IVW estimate is
biased. The test of whether the intercept differs from zero
is referred to as the MR-Egger intercept test.
Intuitive motivation for MR-Egger analysis
Figure 2 provides two examples where the estimates from
the IVW and MR-Egger methods differ substantially. The
left panel of Fig. 2 is a simulated illustration, whereas the
right panel is a real-data example where the risk factor is
plasma urate and the outcome is coronary heart disease
(CHD) risk [10] (the choice of genetic variants and the
associations with plasma urate are taken from White et al.
[10]; associations with CHD risk are taken from the
CARDIoGRAMplusC4D consortium 2015 data release
[23], see Web Table A1 in supplementary material). The
horizontal axis of the graph displays the estimated genetic
associations with the risk factor (b^Xj); the vertical axis
displays estimated genetic associations with the outcome
(b^Yj). Each point on the graph represents a single genetic
variant; lines represent 95% confidence intervals for the
genetic associations. For any individual genetic variant, the
ratio estimate h^j is the gradient of the line connecting the
relevant datapoint to the origin. The IVW estimate (solid
line) is a weighted mean of these ratio estimates.
Although all five of the genetic variants in Fig. 2 (left
panel) individually suggest a positive causal effect of the
risk factor on the outcome, a dose–response relationship in
the associations is absent. Genetic variants that have a
greater magnitude of association with the risk factor do not
also have a greater magnitude of association with the
outcome. This is contrary to what would be expected if the
associations of the genetic variants with the outcome were
entirely mediated via the risk factor, and hence it is unli-
kely that all of the genetic variants are valid instrumental
variables. While the individual ratio estimates are all pos-
itive (as is the IVW estimate), the regression model from
MR-Egger (dashed line) tells a different story. The inter-
cept term from MR-Egger regression differs from zero, and
the causal estimate from MR-Egger is compatible with the
null. This suggests that the set of genetic variants suffers
from directional pleiotropy and, once this pleiotropy is
accounted for, there is no residual evidence for a causal
effect. A similar situation applies to the example of plasma
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urate and CHD risk in Fig. 2 (right panel) [24]. In contrast,
the simple and weighted median methods of Bowden et al.
[25] would give similar estimates to the IVW method in
Fig. 2 (left panel). In Fig. 2 (right panel), estimates from
the different methods (odds ratio per 1 standard deviation
increase in plasma urate with 95% confidence interval) are
1.11 (1.03, 1.20) for the IVW method, 1.00 (0.90, 1.10) for
the MR-Egger method, 1.05 (0.99, 1.11) for the weighted
median method, and 1.20 (1.07, 1.34) for the simple
median method.
A conventional Mendelian randomization analysis—
defined as an analysis in which the instrumental variable
assumptions are assumed to hold for all of the genetic
variants—assesses whether genetic variants that are asso-
ciated with the risk factor also associate with the outcome.
Median-based methods assess whether the majority (or
weighted majority) of genetic variants are associated with
the outcome. In comparison, MR-Egger assesses whether
there is a dose–response relationship between the genetic
associations with the risk factor and those with the
outcome.
Orientation of the genetic variants
Genetic associations are usually the per allele associations
of the genetic variants with the risk factor and with the
outcome. Associations of genetic variants (assumed here to
be single nucleotide polymorphisms, SNPs, although other
polymorphisms could also be considered) can be quoted
with respect to either the major or the minor allele. For
example, if a genetic variant has a C allele and a T allele,
the association could equivalently be given as (say) 0.243
units per additional copy of the C allele, or as 0:243 units
per additional copy of the T allele. There is no prior reason
why one orientation should be preferred over the other.
Figure 3 displays associations for the same variants as
in Fig. 2 (left panel), except that three of the variants are
positively orientated (orientated with respect to the risk
factor-increasing allele), and two are negatively orien-
tated. For the IVW estimate (solid line), the lack of
intercept in the regression model means that a genetic
variant provides exactly the same contribution to the
analysis when orientated with respect to the either allele.
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Fig. 2 Graph showing simulated (left panel) and real-data (right
panel) examples in which inverse-variance weighted estimate (solid
line) and MR-Egger estimate (dashed line) differ substantially. Each
point represents the per allele associations of a single genetic variant
(lines from each point are 95% confidence intervals for the
associations). In both cases, the inverse-variance weighted estimate
is positive, whereas the MR-Egger causal estimate is null with
intercept term differing from zero
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Fig. 3 Graph showing same simulated example as in Fig. 2 (left
panel), except that three variants are positively orientated and two
negatively. The inverse-variance weighted estimate (solid line) is
unaffected by the orientation of variants, whereas the MR-Egger
estimate (dashed line) is affected by the choice of orientation, with
the intercept term attenuating and the MR-Egger estimate approach-
ing the inverse-variance weighted estimate
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However, in the MR-Egger analysis (dashed line),
changing the orientation of any one genetic variant will
change the definition of the pleiotropic effect aj (Eq. 1),
and also the assessment of directional pleiotropy and
the InSIDE assumption itself.
To address this issue, we orientate the genetic variants
so that the associations with the risk factor all have the
same sign. This means that directional pleiotropy is defined
with respect to the risk factor-increasing allele (or equiv-
alently, the risk factor-decreasing allele). Orientating the
genetic variants in this way means that the MR-Egger
analysis does not depend on the original coding of the
genetic variants, and directional pleiotropy is perhaps more
likely to be detected. It will be detected if pleiotropic
effects tend to act in a consistent direction that corresponds
to increases (or decreases) in the risk factor (particularly if
the InSIDE assumption is additionally violated and genetic
variants having greater associations with the risk factor
also have larger pleiotropic effects).
As genetic variants included in a Mendelian random-
ization analysis are usually chosen as those having statis-
tically robust associations with the risk factor, it is unlikely
that the identity of the risk factor-increasing allele for a
genetic variant is uncertain. However, if a genetic variant
has a weak association with the risk factor, then a small
change in its association with the risk factor from positive
to negative will change its orientation in the MR-Egger
analysis, thus potentially having a large impact on the MR-
Egger causal estimate and intercept terms. This situation
may arise if the genetic variants are chosen with respect to
one variable, but associations are estimated with respect to
a related variable (for example, genetic variants are chosen
on the basis of their association with body mass index, but
the risk factor of interest is a site-specific measure of adi-
posity) or are estimated in another population (for example,
genetic variants are chosen on the basis of their association
in European-descent individuals, but the associations used
in the analysis are estimated in African-descent individu-
als). It may be prudent in such a situation to orientate
variants according to their associations in the larger
dataset.
Interpretation of results from the MR-Egger
method
In this section, we present issues relating to the inter-
pretation of results from the MR-Egger method, includ-
ing the precision of estimates, influence of outlying
variants, violations of the InSIDE assumption, and situ-
ations where the MR-Egger and conventional methods
give differing results.
Precision of the MR-Egger estimate
In the IVW method, the estimated variance of the causal
estimate from the regression analysis is proportional to the
weighted sum of the squares of the b^Xj estimates:
Variance of the IVW estimate ¼ r^
2
P
j b^
2
Xjseðb^YjÞ2
ð5Þ
where r^ is the estimated residual standard error from
Eq. (3); this is 1 when using a fixed-effect meta-analysis
model for combining the ratio estimates, corresponding to
the assumption of no heterogeneity in the causal estimates
from the individual genetic variants [26]. A random-effects
model that allows for multiplicative overdispersion in these
causal estimates should be preferred if there is suspicion of
potential pleiotropy. This can be achieved by estimating
the residual standard error as part of the analysis (a mul-
tiplicative random-effects model); an estimate of the
residual standard error above 1 corresponds to overdis-
persion of the genetic associations [21]. However, if the
estimate of the residual standard error is less than 1, then
this is not plausible (for uncorrelated variants), as there is
no biological mechanism that would lead to underdisper-
sion of the genetic associations. Therefore standard errors
of the regression coefficients should be corrected by
dividing by the minimum of the residual standard error
estimate and one, so that a random-effects model can never
give more precise estimates than a fixed-effect model.
Underdispersion may be a sign that the genetic variants
may have been chosen inappropriately in a way that pref-
erentially selects similar variants. However, it may simply
be a chance finding.
In the MR-Egger method, the variance of the causal
estimate is inversely proportional to the weighted variance
of the b^Xj estimates:
Variance of the MR-Egger estimate
¼ r^
02
P
jðb^Xj  bXÞ2seðb^YjÞ2
:
ð6Þ
where r^0 is the estimated residual standard error from
Eq. (4), and bX is the weighted average association with
the risk factor amongst the genetic variants (using the
inverse-variance weights seðb^YjÞ2) [27]. As pleiotropic
effects of genetic variants will lead to overdispersion in the
MR-Egger regression model, heterogeneity between the
causal estimates is expected, and so a random-effects
analysis should always be preferred when using MR-Egger.
If heterogeneity is absent, then a random-effects analysis is
equivalent to a fixed-effect analysis.
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While the precision of the IVW estimate depends on the
proportion of variance in the risk factor explained by the
genetic variants (typically measured by the R2 statistic) [28],
the precision of the MR-Egger estimate additionally
depends on the variability between the genetic associations
with the risk factor [29]. In a hypothetical case where several
genetic variants have almost equal associations with the risk
factor, the IVW estimate may be very precise, particularly if
the associations with the outcome are similar to each other
(Fig. 4; left panel—grey area represents 95% confidence
interval for the IVW estimate). However, in the MR-Egger
analysis, the precisions of the intercept and causal estimates
will be low (Fig. 4; right panel—grey area represents 95%
confidence interval for the MR-Egger intercept and causal
estimate). This behaviour can be diagnosed using the I2
statistic from the meta-analysis literature as proposed by
Bowden et al. [29]. The Bowden I2 statistic is a measure of
instrument strength for the MR-Egger method; values close
to one indicate that the MR-Egger estimate does not suffer
from ‘weak instrument bias’. In fact, if the genetic associ-
ations with the risk factor are exactly equal, then neither
parameter in the MR-Egger regression model is formally
identified, and the I2 statistic is zero.
As an illustration of this, despite broad consistency of
the causal estimates across the genetic variants in Fig. 4
(right panel), the MR-Egger analysis is not able to reliably
detect a dose–response relationship in the genetic associ-
ations with the risk factor and with the outcome, and hence
cannot distinguish between pleiotropy and a causal effect.
The standard error of the causal estimate from the MR-
Egger method will typically be larger than that from the
IVW method; this will always be the case for fixed-effect
analyses. A precise MR-Egger estimate requires genetic
variants having a wide range of associations with the risk
factor. However, as we discuss next, if one genetic variant
has a much stronger association with the risk factor than
others, then this variant will have a large influence on the
coefficients in the MR-Egger regression.
Influence of outlying variants on MR-Egger
estimates
In any regression model, an individual datapoint can have a
large influence on the regression coefficients. In Fig. 5 (left
and right panels), we see how the addition of a single
genetic variant can reverse the sign of the MR-Egger
estimate, and lead to rejection of the MR-Egger intercept
test. The influence on the IVW estimate is less severe. This
scenario is particularly likely for a risk factor such as body
mass index, where the lead variant in one gene region (the
FTO gene region) has a much stronger association with the
risk factor than other variants [30]. Influential points can be
detected by standard regression diagnostic tools, such as
calculating Cook’s distances and/or Studentized residuals
for all the datapoints [31], and performing a leave-one-out
analysis [32]. Cook’s distance is a measure of leverage,
indicating the influence of a datapoint on the regression
estimates (larger values indicate greater influence). A
Studentized residual is a residual from the regression
model divided by an estimate of its standard error, indi-
cating the goodness-of-fit in the regression model for that
point (larger values indicate more outlying points). A
leave-one-out analysis is conducted by leaving each
genetic variant out of the Mendelian randomization anal-
ysis in turn, conducting J analyses each with J  1
datapoints.
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Fig. 4 Graph showing hypothetical example in which genetic
associations with the risk factor and with the outcome are similar
for all variants. Left panel inverse-variance weighted estimate (solid
line) and 95% confidence interval (grey area) suggest strong evidence
for a positive causal effect. Right panel MR-Egger estimate (dashed
line) and 95% confidence interval (grey area) suggest no evidence
against the instrumental variable assumptions (intercept test), but also
no evidence for a causal effect (causal test)
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We calculated Cook’s distances and Studentized resid-
uals for all the variants included in the MR-Egger analysis
of plasma urate and CHD risk presented in Fig. 2 (right
panel). The genetic variant with both the largest Cook’s
distance and Studentized residual was not one of the two
variants having the greatest association with plasma urate,
but the variant having the strongest association with CHD
risk (rs653178, nearest gene ATXN2). However, the omis-
sion of this variant did not substantially affect the MR-
Egger analysis (neither the rejection of the intercept test,
nor the failure to detect a causal effect).
Plausibility and violations of the InSIDE assumption
While the MR-Egger intercept test does not require the
InSIDE assumption to be satisfied to detect violations of
the instrumental variable assumptions, the interpretation of
the intercept as an average pleiotropic effect, as well as the
assessment and estimation of a causal effect using MR-
Egger, do rely on the InSIDE assumption. Equally,
although the primary assumption for the IVW method is
that all variants are valid instruments, it also provides
consistent estimates when the average pleiotropic effect is
zero and the InSIDE assumption is satisfied. Although the
initial presentation of the MR-Egger method [9] gave
biased estimates with inflated Type 1 error rates when the
InSIDE assumption was not satisfied, the bias and Type 1
error inflation were both less than those for the IVW
method. However, subsequent simulations have shown that
estimates from the MR-Egger method can be more biased
and have greater Type 1 error rates compared with the IVW
method in settings when pleiotropic effects of multiple
genetic variants act through the same confounder [25].
Hence, the InSIDE assumption is crucial to the interpre-
tation of causal inferences from the MR-Egger method in
the case of pleiotropy.
Some general plausibility of the InSIDE assumption can
be inferred from the observation that genetic associations
with different measured variables tend to be uncorrelated
with each other, as demonstrated in empirical studies [33].
If all the genetic variants in a Mendelian randomization
analysis have pleiotropic effects, but the pleiotropic effects
act via unrelated variables that are not confounders of the
risk factor–outcome associations, then the InSIDE
assumption seems likely to hold. However, if the pleio-
tropic effects of several variants all act via the same con-
founder, the pleiotropic effects and instrument strengths
will be strongly correlated, as both depend on the magni-
tude of the associations of the genetic variants with the
confounder. Similarly, if a genetic variant has a pleiotropic
effect via a confounder, then this will lead to an association
with the risk factor (contributing to the instrument strength)
and an association with the outcome (contributing to the
pleiotropic effect). Crucially, if the effect of the genetic
variant on the confounder increases, then its association
with both the risk factor and with the outcome will
increase. This means that genetic variants with larger
effects on confounders will tend to have both larger
instrument strengths and larger pleiotropic effects—leading
to violation of the InSIDE assumption. It is difficult to
imagine how the InSIDE assumption could be satisfied if
several genetic variants have pleiotropic effects acting via
confounders.
Some general plausibility of the InSIDE assumption can
be inferred from the observation that genetic associations
with different measured variables tend to be uncorrelated
with each other, as demonstrated in empirical studies [33].
If all the genetic variants in a Mendelian randomization
analysis have pleiotropic effects, but the pleiotropic effects
act via unrelated variables that are not confounders of the
risk factor–outcome associations, then the InSIDE
assumption seems likely to hold (Scenarios 2 and 3 of
Bowden et al. [9, 25], Fig. 6 top panel). However, if
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Fig. 5 Graph showing same
hypothetical example as Fig. 4
(left panel) except for the
addition of a single extra genetic
variant (right panel). Left panel
inverse-variance weighted
estimate (solid line) and MR-
Egger estimate (dashed line) are
similar. Right panel inverse-
variance weighted estimate
(solid line) and MR-Egger
estimate (dashed line) are
markedly different, as the
influential genetic variant
changes the sign of the MR-
Egger estimate
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genetic variants have pleiotropic effects on the outcome
that all act via the same confounder, the pleiotropic effects
and instrument strengths will be strongly correlated, as
both depend on the magnitude of the associations of the
genetic variants with the confounder (Scenario 4 of Bow-
den et al. [9, 25], Fig. 6 middle panel). Further to this, if
genetic variants have pleiotropic effects on the outcome
that act via different confounders, then the InSIDE
assumption will still be violated (Fig. 6 bottom panel). This
occurs because, if the effect of the genetic variant on the
confounder increases, then its association with both the risk
factor (contributing to the instrument strength) and with the
outcome (contributing to the pleiotropic effect) will
increase. This means that genetic variants with larger
effects on confounders will tend to have both larger
instrument strengths and larger pleiotropic effects ?—
leading to violation of the InSIDE assumption. It is
therefore difficult to imagine how the InSIDE assumption
could be satisfied if several genetic variants have pleio-
tropic effects acting via confounders.
It has been claimed that the InSIDE assumption can be
empirically tested by assessing the correlation between the
ratio estimates for the individual variants and their asso-
ciations with the risk factor [34]. However, the ratio esti-
mate includes the association with the risk factor as its
denominator, so a correlation between the ratio estimates
and the associations with the risk factor would be expected
even if all genetic variants were valid instruments.
Comparing results between MR-Egger
and conventional Mendelian randomization analyses
An important practical issue for the MR-Egger method is
the interpretation of a discordant result from a conventional
Mendelian randomization analysis. We have already seen
examples in which this can occur: Fig. 2 (left and right
panels; positive conventional estimate, null MR-Egger
estimate) and Fig. 5 (right panel; positive conventional
estimate, negative MR-Egger estimate). Another example
is the effect of high-density lipoprotein (HDL) cholesterol
on CHD risk using all genome-wide significant variants
associated with HDL-cholesterol (including variants
known to have pleiotropic effects): the IVW method sug-
gests a protective effect of HDL-cholesterol on CHD risk,
whereas the MR-Egger method detects directional pleio-
tropy and suggests a null causal effect (Fig. 7, details of the
analysis are given in the ‘‘Appendix A.3’’ in supplementary
material) [25]. Estimates from the different methods (odds
ratio per 1 standard deviation increase in HDL-cholesterol
with 95% confidence interval) are 0.78 (0.68, 0.89) for the
IVW method, 0.99 (0.79, 1.24) for the MR-Egger method,
0.93 (0.92, 1.07) for the weighted median method, and 0.77
(0.64, 0.91) for the simple median method. These examples
illustrate the correlation between the intercept term and
slope term in MR-Egger regression: if the intercept term is
close to zero, then the MR-Egger estimate will be close to
the IVW estimate. However, even if the estimates are
similar, inferences from the two methods can differ if the
MR-Egger estimate is imprecise, as in the example of
height on income [11]. In such a case, the MR-Egger
analysis does not provide additional evidence for a causal
effect, but it does not contradict evidence for a causal effect
from a conventional Mendelian randomization analysis
either.
Additionally, if the MR-Egger intercept is larger than
the association of any of the individual genetic variants (as
Fig. 6 Potential violations of the InSIDE assumption. Top panel
pleiotropic effects act directly on the outcome (InSIDE satisfied);
middle panel pleiotropic effects act on the outcome via single
confounder (InSIDE violated); bottom panel pleiotropic effects act on
the outcome via different confounders (InSIDE still violated). Arrows
from the genetic variants to the risk factor may not be present for all
variants; some variants may affect the confounder directly and not the
risk factor. Notation: G1, G2, . . ., GJ , genetic variants; X, risk factor;
Y, outcome; U, confounder. Pleiotropic effects are signified by curved
arrows
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in Fig. 5, right panel), then this implies (under the InSIDE
assumption) that the average pleiotropic effect on the
outcome of a genetic variant is larger in magnitude than the
observed association with the outcome of all of the indi-
vidual genetic variants. This seems implausible, and sug-
gests that the InSIDE assumption is likely to be violated.
The test for directional pleiotropy indicates that the genetic
variants are not all valid instruments, but the negative MR-
Egger estimate is highly dubious as the causal estimates
from each variant in turn are all positive.
Finally, if a conventional Mendelian randomization
analysis suggests no causal effect, then we would be
reluctant to consider evidence from the MR-Egger method,
as the method was proposed as a sensitivity analysis for a
conventional Mendelian randomization analysis. Although
it is possible for pleiotropic effects to bias the conventional
Mendelian randomization estimate towards the null, it
would seem at least as likely for the MR-Egger estimate to
be biased due to violations of the InSIDE assumption or
due to the influence of strong variants.
Discussion
In this paper, we have described the problem of pleiotropy
in Mendelian randomization, and the potential solution to
this problem represented by the MR-Egger method. We
have described how to implement the method, its
assumptions, and various issues that may bias estimates.
Finally, we have discussed how to interpret discordancies
between results from the MR-Egger method and those from
conventional Mendelian randomization methods.
While the MR-Egger method is a worthwhile sensitivity
analysis for Mendelian randomization, it is by no means a
panacea for all violations of the instrumental variable
assumptions. Several of the issues raised in this paper have
potentially serious consequences for MR-Egger estimates.
These include violations of the InSIDE assumption—the
assumption that the pleiotropic effects of the genetic
variants in the analysis are uncorrelated with the associa-
tions of the variants with the risk factor. Violations of this
assumption have been shown to lead to increased bias and
Type 1 error rate inflation in the MR-Egger method com-
pared with conventional methods in realistic simulations
[25]. Another serious issue is that of the influence of out-
lying variants on MR-Egger estimates. We have shown
how even a single genetic variant can have a substantial
influence on a MR-Egger analysis, leading to rejection of
the MR-Egger intercept test and reversal of the sign of the
MR-Egger estimate (Fig. 5). A corollary of this is that
Mendelian randomization analyses using the MR-Egger
method should still seek to use genetic variants that are
valid instrumental variables as far as possible.
Alternative approaches for sensitivity analysis
in Mendelian randomization
MR-Egger is far from the only method for sensitivity
analysis in Mendelian randomization. Several reviews of
such methods exist in the literature [8, 32, 35]. Approaches
divide into those for assessing the validity of the instru-
mental variable assumptions, and robust methods that give
consistent estimates of a causal effect under weaker
assumptions than those of a conventional Mendelian ran-
domization analysis (such as the MR-Egger method) [32].
Robust methods generally fall into two categories: (1)
methods such as MR-Egger, that replace the instrumental
variable assumptions with an alternative assumption or
assumptions that are assumed to hold for the set of genetic
variants (a similar approach for individual-level data was
proposed by Kolesa´r et al. [22]); and (2) overidentification
methods that assume the instrumental variable assumptions
hold for some of the genetic variants, but not necessarily
for all genetic variants. Individual-level data methods
based on this approach have been proposed by Kang et al.
[36], and Windmeijer et al. [37].
A simple summarized data robust method that falls into
the second category is the weighted median method pro-
posed by Bowden et al. [25]. An unweighted median-based
analysis proceeds by calculating the causal estimate from
each genetic variant individually (h^j ¼ b^Yjb^Xj), and then
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Fig. 7 Graph showing further real example in which inverse-variance
weighted estimate (solid line) and MR-Egger estimate (dashed line)
differ substantially. Each point represents the per allele associations
of a single genetic variant (lines from each point are 95% confidence
intervals for the associations). Associations with HDL-cholesterol are
in standard deviation units and associations with CHD risk are log
odds ratios
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calculating the median of these causal estimates. This esti-
mate is consistent for the causal effect provided that at least
50% of the genetic variants are valid instrumental variables,
and is unaffected by a few genetic variants with outlying
causal estimates. As the sample size increases, the causal
estimates from all valid instrumental variables will tend
towards the same value, which will equal the median esti-
mate provided that at least 50% of the genetic variants are
valid instrumental variables [38]. A weighted median
method has also been proposed, in which genetic variants
with more precise causal estimates contribute more weight to
the analysis [25]. The median-based methods may be more
appropriate than the MR-Egger method in scenarios like
those in Figs. 4 and 5 if the majority of variants are valid
instruments. However, in the scenario in Fig. 2 (left panel),
the median-based methods would still suggest a positive
causal effect despite evidence for directional pleiotropy.
Another summarized data method that has robustness to
outlying variants may be a simple variation of the IVW
method using robust regression rather than standard linear
regression. For example, regression using MM-estimation
with Tukey’s bisquare objective function limits the con-
tribution to the analysis from any single genetic variant
[39–41].
No single method should be relied on for causal infer-
ence. A causal finding is more reliable if it is corroborated
by multiple methods, particularly if the methods make
different assumptions [32]. Methods such as MR-Egger are
desirable as sensitivity analyses as they allow all genetic
variants to violate the instrumental variable assumptions;
however they require all genetic variants to satisfy an
alternative assumption. In contrast, overidentification
methods such as the median-based method allow some
genetic variants to violate the instrumental variable
assumptions in an arbitrary way, although the majority of
variants are assumed to satisfy the assumptions. As such, in
applied practice a range of sensitivity analysis should
ideally be presented, as well as assessments as to whether
the instrumental variable assumptions are satisfied for the
genetic variants in the analysis.
Other violations of the instrumental variable
assumptions
Violations of the instrumental variable assumptions in the
MR-Egger method are expressed here as pleiotropic
effects. However, while all violations of the exclusion
restriction assumption (the assumption that the effect of a
genetic variant on the outcome only operates via the risk
factor; this is equivalent to the third instrumental variable
assumption as stated in this paper [6]) can be expressed in
terms of pleiotropy [15], other violations cannot be. For
example, population stratification is the presence of
multiple subpopulations within the sample population [3].
If genetic associations with the risk factor, with the out-
come, or the frequency of genetic variants differ between
these subpopulations, then there may be a spurious asso-
ciation between the genetic variant and the outcome in the
overall population. Such population effects, as well as
selection effects (for example, the sample under analysis
was ascertained conditional on the risk factor, or else the
sample somehow is not representative of the population as
a whole), are likely to lead to all genetic variants violating
the instrumental variable assumptions, and hence consis-
tency conditions for the robust methods presented above
would be unlikely to hold.
Linearity and homogeneity assumptions
Two assumptions that we have made in the specification of
the analysis models for both conventional and MR-Egger
methods are those of linearity and homogeneity of the
causal effect. These assumptions are not necessary to
estimate a causal effect; weaker assumptions (such as
monotonicity [42] or a weaker version of the homogeneity
assumption [43, 44]) can be made [45]. However, the
assumptions of linearity and homogeneity ensure that the
same causal effect is identified by all genetic variants that
are valid instrumental variables. If the linearity and
homogeneity assumptions are violated, then the causal
estimate from a single variant still provides a valid test of
the causal null hypothesis that the risk factor has no causal
effect on the outcome [4]; as does the causal estimate from
the IVW method, as this is a linear combination of the
causal estimates from the individual variants [14].
We view violations of assumptions that lead to inap-
propriate inferences (inflated Type 1 error rate of the null
hypothesis of no causal effect) as first-order concerns,
while violations of assumptions that lead only to inappro-
priate causal estimates (but appropriate causal inferences
both with a null and a non-null causal effect) are viewed as
second-order concerns (and questions about the causal
estimand, such as those arising due to non-collapsibility
with a binary outcome [46], as third-order concerns).
Violations of the assumptions of linearity and homogeneity
of the causal effect are important, as they affect the inter-
pretation of results from MR-Egger and conventional
Mendelian randomization methods, and the applicability of
causal estimates in practice. However, they will not lead to
inappropriate inferences, and as such are less troublesome
than violations of the three core instrumental variable
assumptions. There are many reasons why Mendelian
randomization estimates may differ from the result of
intervening on the risk factor in practice (for example, the
mechanism of the intervention, the duration of the inter-
vention, and the timing of the intervening) [47], and so an
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overly literal interpretation of Mendelian randomization
estimates is rarely justified, even when the instrumental
variable assumptions are satisfied. An important situation
under which the assumptions of linearity and homogeneity
are satisfied for the risk factor–outcome relationship is
when the causal effect is null.
Extension to correlated variants
The IVW estimate has previously been extended to account
for correlated variants, by fitting the regression model of
Eq. (3) using generalized weighted linear regression [14].
Rather than the simple weights seðb^YjÞ2, we use a
weighting matrix X1, where X has elements Xj1;j2 ¼
seðb^Yj1Þseðb^Yj2Þqj1;j2 and qj1;j2 is the correlation between
the j1th and j2th genetic variants. The IVW estimate
accounting for correlation can be calculated either by
matrix algebra using the weighting matrix, or by multi-
plying the genetic associations with the risk factor and
outcome by the Cholesky decomposition of the weighting
matrix, and then implementing a standard linear regression
model with no weighting. A natural extension of the MR-
Egger method with correlated variants can be constructed
by allowing an intercept term in the generalized weighted
linear regression.
With a fixed number of uncorrelated variants, the MR-
Egger estimate is consistent when the weighted covariance
between the genetic associations with the risk factor and
the pleiotropic effects is zero. The analogous result for
consistency in the MR-Egger method with correlated
variants is provided in ‘‘Appendix A.4’’ in supplementary
material. It is unlikely this criterion will be satisfied if all
variants are mutually correlated, as correlations between
the variants are likely to lead to correlations between the
associations with the risk factor and the pleiotropic effects.
However, including more than one variant in each gene
region can improve precision of the causal estimate [48].
Conclusion
A typical frustration for statisticians is that their method-
ological developments are ignored by the applied field. In
the case of the MR-Egger method, the opposite situation is
true – MR-Egger has been taken up by the field perhaps too
rapidly, and often without understanding of the intricacies
of the method and its interpretation. While some of the
cautions expressed in this paper are also present in the
original paper on MR-Egger, others have only come to
light following the application of the method, and trying to
understand its results. Similar concerns have been raised
elsewhere [25, 29, 31, 49].
While we welcome the widespread adoption of MR-
Egger, we hope that this paper aids practitioners in its
appropriate use and interpretation, and that the method
becomes seen rightly as a sensitivity analysis (and a fallible
one) for Mendelian randomization, and one of many sen-
sitivity analyses that can (and should) be used to assess the
plausibility of any finding from an applied Mendelian
randomization investigation.
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